July 28, 2025

Integer Holdings Corporation (ITGR) Stock Analysis: A 29.83% Upside Potential in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors with its robust growth potential and strong analyst..

Tempus AI, Inc. (TEM) Stock Analysis: Harnessing a Robust 75.4% Revenue Growth in Health Information Services

Tempus AI, Inc. (TEM), a healthcare technology leader, is making waves in the Health Information Services industry with its impressive revenue growth and strategic collaborations. Headquartered in Chicago, the company..

Bausch + Lomb Corporation (BLCO) Stock Report: Navigating a 1.01% Potential Upside Amidst Healthcare Growth

Bausch + Lomb Corporation (NYSE: BLCO), a globally renowned name in the eye health sector, presents a complex picture for investors seeking opportunities in the healthcare industry. With a market..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Navigating a Promising 42% Upside in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (MDGL), a biotechnology firm based in West Conshohocken, Pennsylvania, is gaining attention in the healthcare sector for its pioneering approach to treating metabolic dysfunction-associated steatohepatitis (MASH). With..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 54.94% Potential Upside

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare sector, occupies a unique position in the market by focusing on providing managed healthcare services to low-income families and..

Penumbra, Inc. (PEN) Stock Analysis: Unveiling a 33.82% Potential Upside in the Medical Devices Sector

Penumbra, Inc. (NYSE: PEN), a leading player in the medical devices sector, presents a compelling investment opportunity with a potential upside of 33.82%. With a market capitalization of $9.03 billion,..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 30.71% Upside Potential

For investors with a keen eye on the healthcare sector, Bruker Corporation (NASDAQ: BRKR) presents an intriguing opportunity. As a prominent player in the medical devices industry, Bruker has established..

United Therapeutics Corporation (UTHR): Investor Outlook Reveals a 25% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a leading player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors seeking exposure to..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 75.95% Potential Upside in the Biotechnology Sector

Legend Biotech Corporation (NASDAQ: LEGN) stands as a formidable player in the healthcare sector, specifically within the burgeoning biotechnology industry. With a market capitalization of $7.98 billion, Legend Biotech is..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Transitional Phase with Insightful Market Indicators

Charles River Laboratories International, Inc. (NYSE: CRL) stands at the intersection of innovation and essential support services within the healthcare sector, specifically in diagnostics and research. With a market capitalization..

Bristol-Myers Squibb (BMY): Analyst Ratings Signal 15.73% Upside Potential for Investors

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, operates at the forefront of the drug manufacturing industry. The company, headquartered in Princeton, New Jersey, has a storied..

Alnylam Pharmaceuticals (ALNY): Analyst Consensus Highlights Strong Buy Ratings Amid Robust Pipeline

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands out in the biotechnology sector with its innovative approach to therapeutics, focusing on ribonucleic acid interference (RNAi) technology. With a market capitalization of $42.87..

CVS Health Corporation (CVS): Rating Update Reveals 30% Potential Upside, Making It a Buy for Investors

CVS Health Corporation (NYSE: CVS), a leading player in the healthcare plans industry, offers a compelling investment opportunity with notable growth potential. With a market capitalization of $76.79 billion, CVS..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating a 61.65% Potential Upside

Inspire Medical Systems, Inc. (NYSE: INSP), a specialized player in the healthcare sector, offers investors a unique opportunity in the burgeoning field of medical devices aimed at treating obstructive sleep..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook with 20.96% Potential Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing the attention of investors with its significant growth prospects within the healthcare sector, particularly in the biotechnology industry. With a market capitalization of..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Potential 47% Upside Amid Biotech Innovations

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to drug development and a potential upside of 47.19%, according..

Chemed Corp (CHE) Stock Analysis: Exploring a 29.59% Potential Upside in the Healthcare Sector

Chemed Corp (CHE), a prominent player in the healthcare sector, is capturing investor attention with a potential upside of 29.59%, according to current analyst ratings. Incorporated in 1970 and headquartered..

Verona Pharma plc (VRNA) Stock Analysis: Navigating the Biotech Terrain with a $8.95 Billion Market Cap

Investors eyeing Verona Pharma plc (NASDAQ: VRNA) are stepping into the dynamic world of biotechnology, where the company is making strides in developing treatments for respiratory diseases. With a market..

Prestige Consumer Healthcare (PBH) Stock Analysis: A 15% Upside Potential Amid Steady Growth

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands as a noteworthy player in the Healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry. With a market capitalization of..

Elanco Animal Health (ELAN) Stock Analysis: Investor Outlook Reveals 4.19% Potential Upside

For investors seeking opportunities in the healthcare sector, Elanco Animal Health Incorporated (ELAN) presents a compelling case. With a market capitalization of $7.41 billion, Elanco operates within the drug manufacturing..

Search

Funds

July 28, 2025

Search

Funds

July 28, 2025

FTSE 100

Funds